Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm

Chronic obstructive pulmonary disease (COPD) guidelines suggest using inhaled corticosteroids (ICS) in patients with severe airflow limitation or those at high risk of exacerbations. This recommendation is based on evidence demonstrating that ICS, especially when prescribed in fixed-dose combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkie, Morven, Finch, Simon, Schembri, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776680/
https://www.ncbi.nlm.nih.gov/pubmed/25774769
http://dx.doi.org/10.3109/15412555.2014.995288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776680/
https://www.ncbi.nlm.nih.gov/pubmed/25774769
http://dx.doi.org/10.3109/15412555.2014.995288

Ejemplares similares